Modularized Genes in an Adrenal Pathway Reveal a Novel Mechanism in Hypertension Pathogenesis

Area of Science:

• Genetics and Physiology
• Hypertension Research
• Mammalian Biology

Background:

• Human studies have identified quantitative trait loci (QTLs) for blood pressure (BP), but their underlying pathogenic mechanisms remain unclear.
• Understanding these mechanisms is crucial for developing effective hypertension treatments.

Purpose of the Study:

• To physiologically analyze the in vivo effects of individual and combined QTLs on BP.
• To identify novel pathways involved in hypertension pathogenesis.

Main Methods:

• Congenic knock-in genetics were used to study the BP effects of specific QTLs.
• Analysis of individual and combined QTL effects on BP, aldosterone production, and renal/cardiac functions.

Main Results:

• Individual QTLs demonstrated significant BP effects in vivo (33.8–59.8%).
• Combinations of QTLs showed additive effects, suggesting involvement in the same regulatory pathway.
• A novel hypertension pathway regulated by the CUE domain containing 1 protein (Cuedc1) was identified.
• CUEDC1 modulates BP, aldosterone, and renal/cardiac functions, with conserved mechanisms across mammals.

Conclusions:

• The CUE domain containing 1 protein (Cuedc1) represents a novel target for understanding and potentially treating hypertension.
• Shared BP regulation mechanisms involving CUEDC1 in humans and rodents provide a basis for translational research.
• Future research integrating genetic discoveries with physiological model studies is essential for advancing hypertension research.